In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Planned Parenthood provides vital HIV services for both women and men.
HIV-positive singer and activist Sherri Lewis is cured of hepatitis C.
POZ editor in chief Oriol R. Gutierrez Jr writes about the March 2016 issue of POZ.
This month’s letters celebrate the 2015 POZ 100 and reflect on the FDA’s new policy on gay blood donors.
ASCNYC executive director Sharen Duke reflects on 25 years of service and the future of the organization.
An exhibit of ‘When Dogs Heal’ their HIV-positive owners
A roundup of books on HIV and addiction
San Francisco’s new one-stop shop for HIV, health and wellness at 470 Castro Street
“We Are Family,” a campaign by Greater Than AIDS and the Georgia Department of Public Health, sparks talk about HIV.
To promote HIV testing , the CDC’s Act Against AIDS initiative launched a campaign titled “Doing It.”
In a first for a major American insurer, Prudential Financial is offering individual life insurance policies.
Durex started a #CondomEmoji campaign to convince the Unicode Consortium to add a condom to everyone’s emoji library.
Media coverage of HIV looks to improve, thanks to a $130,000 grant from the CDC to NLGJA: The Association of LGBT Journalists.
Vickie Lynn, MSW, MPH, is an advocate living with HIV who argues for the need to continue working together.
Being undetectable means that it’s nearly impossible to transmit HIV to your partners. Here are the responses to our undetectable survey.
A considerable proportion of HIV transmissions take place when someone has recently contracted the virus or has interrupted ARV treatment.
A placebo-controlled Phase IIa study of BMS-955176 has shown that the experimental ARV is potent, safe and well-tolerated.
Scientists have created a two-headed protein that awakens latently HIV-infected immune cells and summons an immune response to kill them.
People with HIV who have mild cognitive impairment are at increased risk of developing symptoms of impairment.
The FDA has approved Gilead Sciences’ Harvoni to treat the virus for genotypes 4, 5 or 6 of hep C, and in those coinfected with HIV.
Treating HIV without the need for daily meds may become a reality by the decade’s end.
People coinfected with HIV and hepatitis C virus (HCV) have a much lower risk of death after ridding themselves of HCV.
The FDA has approved Gilead Science’s Genvoya, which is the first HIV treatment to include an updated version of tenofovir.
A considerable proportion of the cancers that develop in HIV-positive Americans spawn from other infections.
Bamby Salcedo is a long-term survivor of HIV who has been working in AIDS advocacy for the past 15 years.